BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 21986346)

  • 21. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of diabetes drug counseling by pharmacist, diabetic disease booklet and special medication containers on glycemic control of type 2 diabetes mellitus: a randomized controlled trial.
    Suppapitiporn S; Chindavijak B; Onsanit S
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S134-41. PubMed ID: 16623018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes.
    Farmer AJ; Perera R; Ward A; Heneghan C; Oke J; Barnett AH; Davidson MB; Guerci B; Coates V; Schwedes U; O'Malley S
    BMJ; 2012 Feb; 344():e486. PubMed ID: 22371867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health and Psychosocial Outcomes of a Telephonic Couples Behavior Change Intervention in Patients With Poorly Controlled Type 2 Diabetes: A Randomized Clinical Trial.
    Trief PM; Fisher L; Sandberg J; Cibula DA; Dimmock J; Hessler DM; Forken P; Weinstock RS
    Diabetes Care; 2016 Dec; 39(12):2165-2173. PubMed ID: 27456837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Motivational enhancement therapy with and without cognitive behavior therapy to treat type 1 diabetes: a randomized trial.
    Ismail K; Thomas SM; Maissi E; Chalder T; Schmidt U; Bartlett J; Patel A; Dickens CM; Creed F; Treasure J
    Ann Intern Med; 2008 Nov; 149(10):708-19. PubMed ID: 19017589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment.
    Nauck MA; Haastert B; Trautner C; Müller UA; Nauck MA; Heinemann L;
    Diabetologia; 2014 May; 57(5):868-77. PubMed ID: 24445534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ROSES: role of self-monitoring of blood glucose and intensive education in patients with Type 2 diabetes not receiving insulin. A pilot randomized clinical trial.
    Franciosi M; Lucisano G; Pellegrini F; Cantarello A; Consoli A; Cucco L; Ghidelli R; Sartore G; Sciangula L; Nicolucci A;
    Diabet Med; 2011 Jul; 28(7):789-96. PubMed ID: 21342243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The longitudinal association between glycaemic control and health-related quality of life following insulin therapy optimisation in type 2 diabetes patients. A prospective observational study in secondary care.
    Hajos TR; Pouwer F; de Grooth R; Holleman F; Twisk JW; Diamant M; Snoek FJ
    Qual Life Res; 2012 Oct; 21(8):1359-65. PubMed ID: 22065281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of Targeted Insulin-Adherence Interventions for Glycemic Control Using Predictive Analytics Among Patients With Type 2 Diabetes: A Randomized Clinical Trial.
    Lauffenburger JC; Lewey J; Jan S; Makanji S; Ferro CA; Krumme AA; Lee J; Ghazinouri R; Haff N; Choudhry NK
    JAMA Netw Open; 2019 Mar; 2(3):e190657. PubMed ID: 30874782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial.
    Church TS; Blair SN; Cocreham S; Johannsen N; Johnson W; Kramer K; Mikus CR; Myers V; Nauta M; Rodarte RQ; Sparks L; Thompson A; Earnest CP
    JAMA; 2010 Nov; 304(20):2253-62. PubMed ID: 21098771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pro-active call center treatment support (PACCTS) to improve glucose control in type 2 diabetes: a randomized controlled trial.
    Young RJ; Taylor J; Friede T; Hollis S; Mason JM; Lee P; Burns E; Long AF; Gambling T; New JP; Gibson JM
    Diabetes Care; 2005 Feb; 28(2):278-82. PubMed ID: 15677779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of cognitive behavioural group training (CBGT) in adult patients with poorly controlled insulin-dependent (type 1) diabetes: a pilot study.
    Snoek FJ; van der Ven NC; Lubach CH; Chatrou M; Adèr HJ; Heine RJ; Jacobson AM
    Patient Educ Couns; 2001 Nov; 45(2):143-8. PubMed ID: 11687328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychosocial factors associated with use of continuous glucose monitoring.
    Ritholz MD; Atakov-Castillo A; Beste M; Beverly EA; Leighton A; Weinger K; Wolpert H
    Diabet Med; 2010 Sep; 27(9):1060-5. PubMed ID: 20722681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis.
    Umpierre D; Ribeiro PA; Kramer CK; Leitão CB; Zucatti AT; Azevedo MJ; Gross JL; Ribeiro JP; Schaan BD
    JAMA; 2011 May; 305(17):1790-9. PubMed ID: 21540423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus.
    Herz M; Johns D; Reviriego J; Grossman LD; Godin C; Duran S; Hawkins F; Lochnan H; Escobar-Jiménez F; Hardin PA; Konkoy CS; Tan MH
    Clin Ther; 2003 Apr; 25(4):1074-95. PubMed ID: 12809958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated management of type 2 diabetes mellitus and depression treatment to improve medication adherence: a randomized controlled trial.
    Bogner HR; Morales KH; de Vries HF; Cappola AR
    Ann Fam Med; 2012; 10(1):15-22. PubMed ID: 22230826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biophysiologic outcomes of the Enhancing Adherence in Type 2 Diabetes (ENHANCE) trial.
    Sevick MA; Korytkowski M; Stone RA; Piraino B; Ren D; Sereika S; Wang Y; Steenkiste A; Burke LE
    J Acad Nutr Diet; 2012 Aug; 112(8):1147-57. PubMed ID: 22818724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety profile of glimepiride in Mexican American Patients with type 2 diabetes mellitus: a randomized, placebo-controlled study.
    Luis Bautista J; Bugos C; Dirnberger G; Atherton T
    Clin Ther; 2003 Jan; 25(1):194-209. PubMed ID: 12637120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term effects of cognitive behavioural group training (CBGT) in adult Type 1 diabetes patients in prolonged poor glycaemic control. A randomized controlled trial.
    van der Ven NC; Hogenelst MH; Tromp-Wever AM; Twisk JW; van der Ploeg HM; Heine RJ; Snoek FJ
    Diabet Med; 2005 Nov; 22(11):1619-23. PubMed ID: 16241932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis.
    Karagiannis T; Paschos P; Paletas K; Matthews DR; Tsapas A
    BMJ; 2012 Mar; 344():e1369. PubMed ID: 22411919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.